Finance

Beta
Lists
2509:HKG
Qyuns Therapeutics Co Ltd
HK$15.71
+2.15%
(+0.33) 1D
Jun 11, 4:08:28 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2509...
Open
HK$15.02
High
HK$16.24
Low
HK$14.58
Mkt. cap
3.51B
Avg. vol.
254.58K
Volume
132.60K
P/E ratio
9.67
52-wk high
HK$36.50
52-wk low
HK$13.50
EPS
HK$1.62
Shares outstanding
227.07M
No. of employees
337
Open
HK$15.02
High
HK$16.24
Low
HK$14.58
Mkt. cap
3.51B
Avg. vol.
254.58K
Volume
132.60K
P/E ratio
9.67
52-wk high
HK$36.50
52-wk low
HK$13.50
EPS
HK$1.62
Shares outstanding
227.07M
No. of employees
337
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to 2509 in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for 2509 in the last 3 months.
Highest
Current HK$15.71
HK$37.35 (+137.75%)
Average
HK$33.50 (+113.24%)
Lowest
HK$30.15 (+91.92%)
News stories
From sources across the web
About Qyuns Therapeutics Co Ltd
CEO-
Employees337
Founded2015
Headquarters-
SectorBiotechnology
Websiteqyuns.net
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
103.24M
103.24M
300.24M
300.24M
Cost of goods sold
14.43M
14.43M
31.84M
31.84M
Cost of revenue
14.43M
14.43M
31.84M
31.84M
Research and development expenses
75.70M
75.70M
50.89M
50.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.34M
24.34M
40.86M
40.86M
Operating expense
99.31M
99.31M
92.83M
92.83M
Total operating expenses
113.74M
113.74M
124.67M
124.67M
Operating income
-10.50M
-10.50M
175.57M
175.57M
Other non operating income
-924.00K
-924.00K
-543.00K
-543.00K
EBT including unusual items
-15.48M
-15.48M
169.17M
169.17M
EBT excluding unusual items
-16.26M
-16.26M
168.90M
168.90M
Income tax expense
-18.50K
-18.50K
-18.00K
-18.00K
Effective tax rate
0.12%
0.12%
-0.01%
-0.01%
Other operating expenses
-725.50K
-725.50K
-224.50K
-224.50K
Net income
-14.17M
-14.17M
171.39M
171.39M
Net profit margin
-13.72%
-13.72%
57.09%
57.09%
Earnings per share
-
-
-
-
Interest and investment income
2.02M
2.02M
2.24M
2.24M
Interest expense
-5.27M
-5.27M
-4.34M
-4.34M
Net interest expenses
-3.25M
-3.25M
-2.10M
-2.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.87M
-2.87M
183.20M
183.19M
Gain or loss from assets sale
-
-
95.00K
95.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more